SEC Form D · filed January 6, 2016
Apellis Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Federico S. Grossi · Crestwood, KYExecStephanie S. O'Brien · Newton, MADirectorDavid S. Watson · Crestwood, KYExecGerald S. Chan · Newton, MADirectorCedric J. Francois · Crestwood, KYExec · DirectorA. S. Dunlop · Bethesda, MDDirectorAlec S. Machiels · Crestwood, KYDirectorDaniel S. Geffken · Crestwood, KYExecBihua S. Chen · Boston, MADirectorNicole S. Perry · Crestwood, KYExecPascal Deschatelets · Crestwood, KYExecAlexander Allodi · Chicago, ILDirectorKevin Allodi · Chicago, ILExecNicholas R. Zelenczuk · Halifax, Z4ExecGregory M. Friedman · ATLANTA, GAExec · DirectorHoward Tullman · Chicago, ILExecMichael Druga · RALEIGH, NCExecMathew M. Crosswy · ATLANTA, GAExec · DirectorRobert M. Woomer · ATLANTA, GAExec · DirectorSs Hotel Credit Opportunity Fund, LLC · ATLANTA, GAExec · DirectorDavid Dworsky · Gardena, CADirectorStorm Venture Associates V, L.L.C · MENLO PARK, CADirectorDominic A. Bassani · Crestone, CODirectorRyan R. Selwood · Halifax, Z4ExecJoshua S. Phillips · Wakefield, MADirectorPhilip C. Wolf · Montreal, Quebec, CanadaExecSophie Forest · Montreal, Quebec, CanadaExecJeff C. Fagnan · Montreal, Quebec, CanadaExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗